Seeing Is Believing
NBIX is currently covered by 22 analysts with an average price target of $150.05. This is a potential upside of $16.39 (12.26%) from yesterday's end of day stock price of $133.66.
Neurocrine Biosciences's activity chart (see below) currently has 239 price targets and 216 ratings on display. The stock rating distribution of NBIX is 51.22% BUY, 47.56% HOLD and 1.22% SELL.
Analysts average stock forecasts to be materialized ratio is 85.13% with an average time for these price targets to be met of 238.16 days.
Highest price target for NBIX is $200, Lowest price target is $100, average price target is $150.05.
Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 13-Mar-2024.
Currently out of the existing stock ratings of NBIX, 42 are a BUY (51.22%), 39 are a HOLD (47.56%), 1 are a SELL (1.22%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
200
$60.56 (43.43%)
165
1 months 10 days ago
14/22 (63.64%)
$58.2 (41.04%)
332
Buy
148
$8.56 (6.14%)
134
2 months ago
14/15 (93.33%)
$13.82 (10.30%)
344
Hold
140
$0.56 (0.40%)
127
2 months 15 days ago
2/2 (100%)
$5.58 (4.15%)
22
Hold
140
$0.56 (0.40%)
127
2 months 15 days ago
5/5 (100%)
$5.58 (4.15%)
57
Hold
140
$0.56 (0.40%)
114
2 months 15 days ago
9/9 (100%)
$5.58 (4.15%)
66
What is NBIX (Neurocrine Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?
Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?